John Runions is a Professor in Cell and Molecular Biology at the School of Biological and Medical Sciences, Oxford Brookes University. His research employs advanced laser microscopy and fluorescent protein technology to study dynamic interactions within living plant cells, focusing on how cellular structures govern growth and environmental responses. Research Focus: His work spans plant cell biology, protein dynamics, membrane biophysics, and stress adaptation. Key themes include the role of the cell wall in regulating membrane nanodomains, actin cytoskeleton behavior under abiotic stress, and molecular mechanisms of plant-environment interactions. Teaching & Advising: He leads the undergraduate module 'Cell Biology and Genetics' and supervises PhD and Master's students. Current projects explore endoplasmic reticulum structure-function relationships in plants, supported by a Biotechnology & Biological Sciences Research Council (BBSRC) grant (£400,317; 2023-2026).
Prof. Dr. Volker Müller is Professor and Head of the Department of Molecular Microbiology and Bioenergetics at Johann Wolfgang Goethe University Frankfurt am Main, Germany. He is a leading figure in microbial bioenergetics, with extensive contributions to understanding anaerobic metabolism, acetogenic bacteria, and extremophile adaptation. Education: Diplom (Biology), Georg-August-University Göttingen, 1985 Dr. rer. nat. (Microbiology), Georg-August-University Göttingen, 1987 Research Interests: Prof. Müller's research spans three major areas: (1) Metabolism and biochemistry of anaerobic microorganisms , including acetogenic bacteria and methanogenic archaea; (2) Biotechnology and metabolic engineering , focusing on syngas fermentation and synthetic microbiology; and (3) Molecular basis of salt adaptation in halophilic and halotolerant microbes. His work has pioneered insights into electron bifurcation, ATP synthases, and energy conservation mechanisms. Recent Publications: His recent work (2023–2025) has been published in high-impact journals such as Nature Communications , Joule , and FEBS Journal , focusing on the Rnf complex, CO 2 reduction, hydrogenases, and metabolic engineering of acetogens for biotechnology applications. Awards and Honors: ERC Advanced Investigator Grant (2017) Heisenberg Fellowship, German Science Foundation (1996) Young Investigator Award, German Society for Hygiene and Microbiology (1995) Ph.D. Thesis Award, German Society for General and Applied Microbiology (1988) Professional Roles: He has served as Editor for Environmental Microbiology and Applied and Environmental Microbiology , and as Director of the Institute of Molecular Biosciences and the Center of Membrane Proteomics. He is currently leading the DFG Research Unit 2251 on Acinetobacter baumannii . Labs and Teams: Prof. Müller heads the Molecular Microbiology & Bioenergetics group at Goethe University, which includes postdocs, PhD students, and technical staff. The lab is equipped for cutting-edge research in microbial physiology, structural biology, and metabolic engineering.
Hong Chen is a Principal Investigator at Boston Children's Hospital and an Associate Professor of Surgery at Harvard Medical School . Their work bridges vascular biology, computational methods, and metabolic disease research, with a focus on atherosclerosis, diabetes, and lymphatic system regulation. Harvard Medical School, Department of Surgery Boston Children's Hospital, Chen Lab Research spans endothelial cell signaling , single-cell RNA sequencing , and metabolite-mediated communication . Key areas include: FOXM1/Dab2 pathways in diabetic wound healing Epsin proteins in atherosclerosis and lipid metabolism Development of MEBOCOST algorithm for metabolite-CRC detection CXCL12/CXCR4 in neuro-lymphatic communication VEGFR3 and caveolae inhibition in lymphatic fate determination Recent publications highlight machine learning applications for cell identity genes, metabolite signaling in adipose tissue, and transcriptional regulators in cardiovascular disease. No explicit scientific awards or student advisement details were found in the provided text.
Ruya Liu is an Assistant Professor in the Department of Physiology and Pharmacology at the University of Maryland, Baltimore School of Medicine (UMB SOM), where she serves as Physiology & Pharmacology Assistant Track Leader for the Graduate Program in Life Sciences (GPILS) Molecular Medicine PhD Program and lectures in graduate courses including Muscle Cell Biology and Cardiac Muscle Physiology. Her educational foundation includes: Bachelor's Degree in Clinical Medicine (BM) from Beihua University Faculty of Medicine, China (2007; Outstanding Graduate Top 1%) PhD in Medicine from Shanghai Jiaotong University School of Medicine, China (2012; Outstanding Graduate Top 5%) Dr. Liu's research centers on molecular mechanisms of cardiomyocyte homeostasis, cardiac metabolism, and regeneration. Her lab pioneered the discovery of TEAD1's critical roles in cardiomyocyte contractility, perinatal replication, and mitochondrial quality control, and recently identified C5x (RIMOC1) as a novel regulator of cardiomyocyte turnover. Her work uniquely bridges cardiac biology with pancreatic beta-cell proliferation and circadian regulation of adipogenesis, revealing conserved Hippo-TEAD pathway functions across metabolic tissues. Analysis of her 2020-2025 publications reveals three dominant themes: (1) Mitochondrial regulation in cardiomyocytes and beta-cells (40% of recent work), (2) Circadian control of adipocyte development via cytoskeletal signaling (30%), and (3) Novel regulators of cardiac regeneration like C5x (30%). Her research consistently connects fundamental molecular mechanisms to translational applications in heart failure, diabetes, and metabolic syndrome. Her scientific recognition includes: American Heart Association Career Development Award (2019) NHLBI Keystone Symposium Scholarship (2015) Baylor College of Medicine Best Presentation Award (2015) Multiple Outstanding Graduate honors in China Dr. Liu actively mentors graduate students and has secured substantial research funding: Current PI: NHLBI R56 grant (2024-2025) on C5ORF51 in cardiomyocyte homeostasis Previous PI: AHA Career Development Award (2019-2023), Samuel and Emma Winters Foundation grant, two University of Pittsburgh institutional grants Co-I: NIH/NIDDK R01 (2014-2019), VA Merit award (2016-2021), NIH/NHLBI R01 (2021) Her laboratory at UMB SOM employs conditional cardiomyocyte-specific knockout mouse models to investigate Hippo-TEAD signaling and collaborates with mitochondrial biology and diabetes research teams. The lab has trained multiple undergraduate fellows and graduate students, with ongoing projects focused on translating C5x/RIMOC1 discoveries into cardiac regenerative therapies.
Craig Slattery is an Assistant Professor of Regulatory Affairs & Toxicology at University College Dublin's School of Biomolecular and Biomedical Science. He specializes in toxicology, public safety, and regulatory affairs, with a focus on applying genomics and toxicogenomics approaches to regulatory toxicology. His work encompasses carcinogenesis screening, toxicity assay development (as alternatives to animal methods), epithelial biology, diabetes, renal biology, and drug-induced toxicities. His educational background includes: PhD from University College Dublin Graduate Diploma in University Teaching and Learning (Level 9) from University College Dublin BSc from University College Dublin Slattery's research primarily focuses on kidney disease, diabetic nephropathy, toxicology and toxicogenomics, and kidney cancers. He is particularly interested in the application of novel genomics and toxicogenomics approaches in regulatory toxicology, with emphasis on carcinogenesis and carcinogenicity screening, toxicity assay development, epithelial biology and physiology. His work bridges basic science with regulatory applications, making significant contributions to understanding renal pathophysiology and developing safer pharmaceuticals and chemicals. His publication record demonstrates a consistent focus on renal toxicology, with particular emphasis on mechanisms of chemical-induced kidney injury, biomarker discovery for kidney diseases, and regulatory aspects of toxicology. His research spans from basic molecular mechanisms to clinical applications, with a strong emphasis on developing alternatives to animal testing methods. The trajectory of his work shows increasing integration of genomic and proteomic approaches to understand kidney injury mechanisms and develop better diagnostic tools. His notable achievements include: Teaching Excellence Award (2021) European Registered Toxicologist designation (2012) Government of Ireland Research Fellowship (2009) President of the Irish Society of Toxicology (since 2018) As an educator, Slattery coordinates numerous teaching modules including Public Science Communication, Research Techniques, Advanced Healthcare Regulatory Affairs, and Toxicology Research Projects. He emphasizes exciting and engaging students while imparting values of curiosity, strong communication skills, critical evaluation, and healthy skepticism. His science communication expertise extends to public outreach, where he specializes in communicating complex scientific and medical information to the general public across all media platforms.
Martin Held is a Lecturer at the Department of Biosystems Science and Engineering, ETH Zürich. He holds a PhD in Biotechnology from ETH Zürich (2000) and has industrial experience through a biotech startup focused on biocatalyst manufacturing. Affiliation: Department of Biosystems Science and Engineering, ETH Zürich Research: Development of biocatalytic processes and synthetic biology tools for sustainable chemical production His research integrates interdisciplinary approaches across biocatalysis, synthetic biology, and chemical engineering to create eco-friendly industrial solutions. Recent work includes microbial indigo synthesis and defossilisation strategies for chemical manufacturing. 2025 Trends: Bio-based textile dyes, carbon feedstock alternatives 2023-2022 Work: Protein secretion optimization, antimicrobial engineering Contact: martin.held@bsse.ethz.ch
Dr. Atanu Acharya is an Assistant Professor in the Department of Chemistry at Syracuse University's College of Arts & Sciences. His research focuses on multiscale computational modeling of complex biological systems, with emphasis on long-range charge transport in bacterial respiration, excited-state allostery in light-sensitive proteins, nano-bio interactions, and machine learning applications for redox process modeling. He leads the ACompChemLab, which includes current graduate students Shashith Dass, Pratima Kumari, and Vivanthi Rajendran, and alumni like Micaela Alvarez (selected by NREL's DOE SULI program). Ph.D. in Chemistry, University of Southern California (2016) M.Sc. in Chemistry, Indian Institute of Technology Madras (2011) B.Sc. in Chemistry (Honors), Jadavpur University (2009) Research Pillars: Long-Range Charge Transport: Investigates multi-heme cytochromes' role in bacterial respiration and their biotechnological applications in bioremediation and microbial fuel cells, focusing on outer membrane modulation of charge transport. Excited-State Allostery: Studies light-oxygen-voltage (LOV) and BLUF proteins to understand signal transmission mechanisms from flavin cofactors to output domains, with implications for optogenetics and cellular regulation. Nano-Bio Interfaces: Analyzes nanoplastic interactions with lipid bilayers and membrane proteins using MD simulations, addressing environmental impacts on marine and mammalian cells. Machine Learning Models: Develops ML frameworks to reduce computational costs in calculating redox parameters, enabling efficient modeling of hundreds of cofactors. Recent Research Trends: His publications (2022-2025) reveal a focus on environmental applications of computational biophysics (nanoplastic penetration), optimization of protein-based nanowires, SARS-CoV-2 spike protein interactions, and ML-enhanced redox modeling. Collaborations span institutions like NREL and Georgia State University. Scientific Recognition: National Institutes of Health Maximizing Investigators' Research Award (2023) Best Presentation at Molecular Biomedical (MBM) Seminar Series (2021) Grants & Leadership: Currently leads NIH-NIGMS grant "Investigation of Long-Range Charge Transfer and Excited State Processes" (2023-2028). Serves on Biochemistry Steering Committee, Graduate Admission Committee, and Faculty Hiring Committee. Laboratory & Team: The ACompChemLab at Syracuse University develops computational tools for photoinduced processes and electron transfer. Recent additions include postdoc Abhinav Gupta (Lehigh University) and graduate students Shashith Dass, Pratima Kumari, and Vivanthi Rajendran. The lab has produced first-author publications from Suman Maity and Sasthi Mandal.
Dr. Nicole Paczia is a leading researcher at the Max Planck Institute for Terrestrial Microbiology , specializing in Metabolomics and Small Molecule Mass Spectrometry . Her work bridges microbial physiology, synthetic biology, and metabolic engineering, with a focus on understanding and reprogramming biochemical pathways for applications in carbon fixation, human health, and pathogen interactions. Key research areas include metabolomics, enzyme discovery, and microbial community dynamics Recent publications highlight innovations in CO2 reduction, NAD metabolism, and biofilm regulation Her interdisciplinary approach integrates computational modeling, experimental validation, and advanced analytical techniques. Notably, she has contributed to the design of synthetic carbon fixation cycles and the characterization of novel enzymatic mechanisms. While no formal awards or student advisement data are explicitly provided, her prolific publication record underscores her impact in microbial metabolomics.
Jonathan Rivnay is a Professor of Biomedical Engineering at Northwestern University , leading the Rivnay Lab in the development of organic bioelectronic materials and devices. His work focuses on bridging biology and electronics through mixed ionic-electronic conductors like conducting polymers, with applications in neural engineering, tissue regeneration, and diagnostics.
Dr Dharmaraja Allimuthu is an Assistant Professor in the Department of Chemistry at Indian Institute of Technology Kanpur , where he leads an interdisciplinary chemical-biology laboratory established in 2018. His group integrates synthetic chemistry, chemical proteomics, and cell-biology approaches to investigate oxidative lipid metabolism and its therapeutic exploitation in cancer and neurodegeneration. Education Ph.D. in Chemical Sciences (2015), IISER-Pune M.Sc. in Chemistry (2005), Bharathidasan University Research Focus Dr Allimuthu’s team pursues three interconnected themes: Ferroptosis Therapeutics: Designing first-in-class small-molecule inducers and inhibitors that reprogram iron-dependent cell death pathways. Chemical Probes: Engineering covalent modifiers for site-selective protein labeling and targeted protein degradation (PROTACs & molecular glues). Lipid Droplet Biology: Creating small molecules that promote endogenous lipid droplet accumulation as a means to modulate lysosomal autophagy (lysophagy). Publication Highlights Across 13 peer-reviewed articles (2012–2025), his work spans organic synthesis, medicinal chemistry, chemical biology, and microbiology. Recent papers illuminate versatile scaffolds for GPX4 inhibition, isatoic anhydride bioconjugation platforms, and redox-modulating iron complexes that trigger apoptosis in cancer cells—demonstrating a trajectory from molecular design to mechanistic validation in cellular and organismal models. Professional Experience Assistant Professor, IIT Kanpur (2018 – present) Post-doctoral Researcher, Case Western Reserve University, Ohio (2015 – 2018) Graduate Research Fellow, IISER-Pune (2010 – 2015) Scientist, Dow Chemical International Private Limited, Pune (2007 – 2009) Laboratory & Facilities The group operates from SL-206 Southern Laboratories, leveraging IIT Kanpur’s state-of-the-art facilities—including mass spectrometry, imaging, and chemical proteomics platforms—to translate chemical tools into next-generation therapeutics.
Dr Christopher Stanley is a leading academic researcher in microvascular physiology and cardiovascular disease, currently serving as Group Lead at the Heart Research Institute (HRI) and Research Affiliate at the University of Sydney. His work focuses on vascular tone regulation, inflammation, and metabolic signaling in sepsis and pregnancy-related complications. Education: BSc in Pharmacology and Physiology (First Class Honours, Leeds Metropolitan University), PhD in Pharmacology (University of Nottingham, 2013) Former affiliations: University of Oxford (postdoctoral work), Victor Chang Cardiac Research Institute (2014-2020) His research spans mitochondrial dysfunction in septic arteries, oxidised protein signaling, and novel metabolite identification in sepsis. Current projects include therapeutic strategies to restore vascular function in sepsis and cardiovascular disease. Awarded multiple honors including the Society for Free Radical Research Young Investigator Award, Sydney Cardiovascular Symposium Rising Star Award, and British Pharmacological Society Competitive Travel Awards.
Abdel A. Abdel-Rahman serves as Professor and Vice Chairman in the Department of Pharmacology & Toxicology at East Carolina University's Brody School of Medicine. His research program is supported by continuous NIH funding exceeding $12 million as Principal Investigator, with current funding through 2R01 AA14441-11 from the National Institute on Alcohol Abuse and Alcoholism (2018-2023). Dr. Abdel-Rahman's research focuses on two primary interconnected areas: 1) Estrogen's paradoxical role in cardiovascular health, investigating how estrogen transforms from protective to harmful in promoting cardiac and neuronal inflammation/injury in women, particularly examining disruption of estrogen modulation of circadian rhythm-regulated redox enzymes and heart-specific micro-RNAs; and 2) The therapeutic potential of the endocannabinoid system, specifically elucidating mechanisms of cannabinoid receptor 1 (CB1R)-mediated cardiovascular effects and the protective role of GPR18 receptor activation. His work reveals critical signaling interactions between adiponectin and biological gases (nitric oxide, hydrogen sulfide, and carbon monoxide) with implications for treating heart disease and diabetes. His publications demonstrate consistent focus on gender-specific cardiovascular responses, with numerous studies examining estrogen receptor signaling, oxidative stress pathways, and neuro-cardiovascular interactions. The research shows particular interest in alcohol- and diabetes-evoked cardiac dysfunction with emphasis on sex differences. Dr. Abdel-Rahman has mentored 14 PhD students, 2 MS students, and 15 postdoctoral scholars throughout his career. His laboratory team currently includes Research Specialist Lindsey Lin and graduate students Mary Katherine Donovan and Collin Brinkley. He has contributed 15 book chapters, with recent contributions to Brody's Human Pharmacology (6th Edition). His work has significantly advanced understanding of gender differences in cardiovascular pharmacology and the therapeutic potential of targeting the endocannabinoid system.
Richard Higashi is a Professor in the Department of Toxicology and Cancer Biology at the University of Kentucky. He serves as Associate Director of the Redox Metabolism Shared Resource Facility at the Markey Cancer Center and is a member of the Cancer Research Priority Initiative and Molecular and Cellular Oncology Research Program. Education: PhD (1987) and BS (1977) from University of California-Davis and University of Hawaii respectively Research: Pioneering stable isotope-resolved metabolomics to study cancer metabolism , metabolic reprogramming , and tumor microenvironment dynamics . Grants: 82 active/finalized grants including NCI-funded projects on mitochondrial redox capacity and immunosuppressive tumor microenvironment targeting. Collaborations: Key partnerships with Anthony N. Lane on cancer metabolism and Qi Wang on colorectal cancer immunotherapy. Scientific Impact: Over 13,000 citations, 47 h-index, with 136 research outputs including 110 original articles . Current projects focus on mitochondrial targeting , metabolic checkpoint inhibition , and precision oncology platforms.
Kristiina Himanen serves as Project Manager of NaPPI (National Plant Phenotyping Infrastructure) and Research Coordinator at the Organismal and Evolutionary Biology Research Program within the Faculty of Biological and Environmental Sciences at the University of Helsinki. She is affiliated with the Viikki Plant Science Centre (ViPS) and holds the title of Docent. Dr. Himanen actively supervises doctoral students in both the Integrative Life Science and Plant Sciences doctoral programmes. Her research spans agricultural biotechnology, plant genetics, developmental biology, and molecular biology, with particular emphasis on plant phenomics and imaging technologies. She specializes in applying high-throughput phenotyping approaches to study plant stress responses, crop resilience, and plant-microbe interactions. Her work integrates cutting-edge imaging techniques with machine learning to advance sustainable agricultural practices, particularly in Nordic conditions. She has developed expertise in controlled environment agriculture, plant disease monitoring, and the application of biostimulants for sustainable crop production. Analysis of her recent publications reveals a strong focus on plant phenotyping technologies, with significant contributions to image-based analysis of plant diseases, stress responses, and growth patterns. Her research bridges fundamental plant biology with practical agricultural applications, particularly in developing climate-resilient crop systems for Nordic regions. She has pioneered approaches using RGB imaging, time-series analysis, and machine learning for plant disease screening and phenotypic characterization. Dr. Himanen has received recognition through the Title of Docent, which qualifies her to supervise doctoral students and teach at the university level. Her editorial contributions include serving as reviewer for journals such as International Journal of Molecular Sciences, Plant Journal, Plants (Basel), and PLoS One, as well as acting as a special issue editor for Plants (Basel). As an active research supervisor, Dr. Himanen participates in numerous collaborative projects and has established herself as a key figure in Nordic plant phenomics infrastructure. She leads significant projects including 'Kuvantamistekn. ratkaisuja kasvihuonetuotannossa' (2023-2026) funded by the Natural Resources Institute Finland, and 'Nordforsk/ Upscaling crop performance' (2023-2026). Her leadership extends to directing the National Plant Phenotyping Facility and related high-throughput imaging systems. Dr. Himanen directs the National Plant Phenotyping Facility and oversees both large and small plant high-throughput image-based phenotyping systems at the Faculty of Biological and Environmental Sciences. Her work with the European Plant Phenotyping Network (EPPN2020) and the EMPHASIS ESFRI project demonstrates her commitment to advancing plant phenomics infrastructure at international levels. She also contributes to the Baltic Wheat Network through the Swedish Institute, focusing on transnational breeding approaches for sustainable wheat production in the Baltic Sea region.
Geraldine M. Grant is an Associate Professor and Chair of the Department of Biology at George Mason University , with a focus on Idiopathic Pulmonary Fibrosis (IPF) and fibroblast biology . She serves as faculty in the Biology Department (Research and Instructional) and affiliate faculty in the School of Systems Biology. Dr. Grant teaches courses including BIOL213 , BIOL498 , and BIOL485 , advocating for undergraduate research through programs like Biology Research Semester and OSCAR Scholars . Education: PhD, Cell Biology & Toxicology, Dublin City University (1993) BA Mod, Biochemistry, Trinity College Dublin (1987) Her research explores how unregulated wound repair by fibroblasts drives IPF, using cell biology , molecular techniques , and 3D tissue models to identify signaling defects , mitochondrial dysregulation , and potential therapeutics . Recent work includes hydrogel models and BI-1 protein studies to target fibroblast survival. Key scientific awards include the Dean’s Mentorship Award (2024) . She collaborates with the Department of Chemistry and Biochemistry , Inova Fairfax Hospital , and NIH , mentoring students in RNA sequencing , cytokine analysis , and drug delivery systems .
